ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue192,925153,612147,588
Cost of Revenue69,13351,82141,801
Gross Profit123,792101,791105,787
Operating Expenses
Research Development32,33726,42121,616
Selling General and Administrative169,668123,212113,317
Non Recurring16,8615,0715,071
Others---
Total Operating Expenses---
Operating Income or Loss-95,074-52,913-29,146
Income from Continuing Operations
Total Other Income/Expenses Net-43,2646282,375
Earnings Before Interest and Taxes-138,338-52,285-26,771
Interest Expense15,8417,4765,709
Income Before Tax-154,179-59,761-32,480
Income Tax Expense498-9,337-62
Minority Interest---
Net Income From Continuing Ops-154,677-50,424-32,418
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-154,677-50,424-32,418
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-154,677-50,424-32,418